Evid Invest
Who owns ERNAWhat ERNA owns — n/a

Who owns Ernexa Therapeutics Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ERNA from SEC Form 13F filings across 11 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 11 institutions disclosed 35,525 shares of Ernexa Therapeutics Inc. worth $236,243 — about 3% of shares outstanding; the largest disclosed holder is CITADEL ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

11

13F holders

$236,243

value, 2026 filers

3%

of shares outstanding (35,525 sh)

11

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ERNA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1CITADEL ADVISORS LLCNEW15,104$100,4420.0%1.3%new
2VANGUARD FIDUCIARY TRUST CONEW8,336$55,4340.0%0.7%new
3Dauntless Investment Group, LLCNEW6,000$39,9000.0%0.5%new
4VANGUARD CAPITAL MANAGEMENT LLCNEW5,684$37,7990.0%0.5%new
5Tradewinds Capital Management, LLCNEW361$2,4010.0%0%new
6BlackRock, Inc.NEW33$2190.0%0%new
7ASSETMARK, INCNEW5$330.0%0%new
8BNP PARIBAS FINANCIAL MARKETSNEW1$70.0%0%new
9SBI Securities Co., Ltd.NEW1$70.0%0%new
10Steward Partners Investment Advisory, LLCNEW0$10.0%0%new
11Activest Wealth ManagementNEW0$00.0%0%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.